ALDX Aldeyra Therapeutics, Inc.

Fundamentals / CIK 0001341235 / USD

Aldeyra Therapeutics, Inc. reported $43.38M in total assets and a net loss of $19.13M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ALDX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$57.99MFY 2016 Net Income: -$18.70M2016FY 2017 Net Income: -$22.34M2017FY 2018 Net Income: -$38.89M2018FY 2019 Net Income: -$60.83M2019FY 2020 Net Income: -$37.55M2020FY 2021 Net Income: -$57.78M2021FY 2022 Net Income: -$62.02M2022FY 2023 Net Income: -$37.54M2023FY 2024 Net Income: -$55.85M2024FY 2025 Net Income: -$33.85M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $25.66M $48.22M $29.46M $47.31M $44.94M $24.68M $44.35M $29.82M $16.30M $13.18M
Operating Income -$35.27M -$60.12M -$42.79M -$62.68M -$56.22M -$36.42M -$63.07M -$39.70M -$22.49M -$18.70M
EBITDA -$35.01M -$59.87M -$42.53M -$62.42M -$55.96M -$36.36M -$62.98M -$39.63M -$22.45M -$18.66M
Interest Income $3.32M $6.19M $7.32M $2.35M $185K $292K $1.54M $953K $261K $102K
Interest Expense $1.91M $1.93M $2.07M $1.69M $1.74M $1.90M $604K $147K $113K $106K
Income Before Tax -- -- -- -- -$57.78M -$38.03M -$62.14M -$38.89M -- --
Income Tax Expense $0 $1.0K $0 $0 $0 -$479K -$1.31M $0 $0 $0
Net Income -$33.85M -$55.85M -$37.54M -$62.02M -$57.78M -$37.55M -$60.83M -$38.89M -$22.34M -$18.70M
Basic EPS -$0.56 -$0.94 -$0.64 -$1.06 -$1.07 -$1.11 -$2.24 -$1.79 -$1.40 -$1.65
Diluted EPS -$0.56 -$0.94 -$0.64 -$1.06 -$1.07 -$1.11 -$2.24 -$1.79 -$1.40 -$1.65
Basic Shares Outstanding 60.1M 59.5M 58.9M 58.4M 54.0M 34.0M 27.1M 21.7M 15.9M 11.4M
Diluted Shares Outstanding 60.1M 59.5M 58.9M 58.4M 54.0M 34.0M 27.1M 21.7M 15.9M 11.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.84M $3.48M $2.41M $4.30M $5.43M $8.51M $7.42M $14.63M
Operating Income -$4.14M -$5.85M -$3.55M -$6.67M -$8.00M -$10.17M -$10.43M -$16.58M
EBITDA -$3.98M -$5.78M -$3.48M -$6.60M -$7.94M -$10.11M -$10.37M -$16.51M
Interest Income $374K $400K $563K $682K $789K $872K $981K $1.24M
Interest Expense $438 $23 $469K $475K $476K $471K $484K $471K
Net Income -$3.76M -$5.45M -$3.45M -$6.46M -$7.69M -$9.77M -$9.93M -$15.81M
Basic EPS -$0.06 -$0.09 -$0.06 -- -$0.13 -$0.16 -$0.17 --
Diluted EPS -$0.06 -$0.09 -$0.06 -- -$0.13 -$0.16 -$0.17 --
Basic Shares Outstanding 60.4M 60.3M 60.3M -- 60.1M 60.0M 59.9M --
Diluted Shares Outstanding 60.4M 60.3M 60.3M -- 60.1M 60.0M 59.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $70.04M $54.53M -- $144.4M $229.8M $77.86M $44.43M $47.36M $20.02M $12.02M
Short-Term Investments $0 $46.62M $0 $29.88M $0 $0 $28.94M $46.24M -- --
Cash & Short-Term Investments $70.04M $101.2M -- $174.3M $229.8M $77.86M $44.43M $47.36M $20.02M $24.90M
Other Current Assets -- $0 $0 $3.24M $29K -- -- -- -- --
Total Current Assets $71.78M $104.1M $147.8M $181.0M $232.8M $83.06M $75.17M $94.77M $43.97M $25.13M
Property, Plant & Equipment, Net $0 $0 $5.8K $19K $32K $60K $148K $235K $43K $56K
Total Non-Current Assets $276K $534K $517K $269K $384K $293K $349K $322K $209K $56K
Total Assets $72.06M $104.6M $148.3M $181.3M $233.1M $83.35M $75.52M $95.09M $44.17M $25.19M
Accounts Payable $158K $180K $1.34M $134K $1.02M $382K $808K $3.05M $1.00M $275K
Short-Term Debt $15.25M $31K $15.15M $912K -- -- -- -- $116K $78K
Deferred Revenue (Current) $6.00M $6.00M $0 -- -- -- -- -- -- --
Total Current Liabilities $27.81M $18.60M $22.26M $15.36M $11.77M $12.41M $12.91M $8.47M $3.35M $2.30M
Long-Term Debt $0 $15.00M $0 $14.92M $15.50M $11.43M $14.53M $16.04M $1.22M $1.24M
Total Non-Current Liabilities $0 $15.00M $6.27M $14.92M $15.63M $11.43M $14.53M $0 $1.22M $1.24M
Total Liabilities $27.81M $33.60M $28.53M $30.28M $27.40M $23.84M $27.44M $8.47M $4.57M $3.54M
Total Debt (incl. Leases) $15.53M $15.30M $15.66M $16.08M $15.86M $11.67M $14.75M $16.04M $1.34M $1.32M
Common Stock $60K $60K $59K $59K $58K $39K $29K $26K $19K $13K
Retained Earnings -$484.0M -$450.1M -$394.3M -$356.7M -$294.7M -$236.9M -$199.4M -$138.5M -$99.64M -$77.30M
Accumulated Other Comp. Income $0 $37K $0 -$104K $0 $0 $5.9K -$9.2K -$18K $129
Total Stockholders' Equity $44.25M $71.00M $119.8M $151.0M $205.7M $59.51M $48.08M $86.62M $39.60M $21.65M
Total Equity $44.25M $71.00M $119.8M $151.0M $205.7M $59.51M $48.08M $86.62M $39.60M $21.65M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents -- -- -- $70.04M $59.34M $41.24M $50.35M $54.53M
Short-Term Investments -- -- -- $0 $15.96M $40.68M $39.71M $46.62M
Cash & Short-Term Investments -- -- -- $70.04M $75.30M $81.92M $90.06M $101.2M
Other Current Assets -- -- -- -- -- -- $756K $0
Total Current Assets $42.92M $47.38M $66.27M $71.78M $77.46M $84.56M $92.73M $104.1M
Property, Plant & Equipment, Net $18K $21K -- $0 -- -- -- $0
Total Non-Current Assets $463K $162K $209K $276K $341K $405K $467K $534K
Total Assets $43.38M $47.54M $66.48M $72.06M $77.80M $84.96M $93.20M $104.6M
Accounts Payable $144K $137K $141K $158K $13K $1.46M $346K $180K
Short-Term Debt $0 $0 $15.30M $15.25M $15.20M $15.15M $0 $31K
Deferred Revenue (Current) -- -- -- $6.00M -- -- -- $6.00M
Total Current Liabilities $7.88M $9.66M $24.33M $27.81M $28.48M $29.53M $14.29M $18.60M
Long-Term Debt -- -- $0 $0 $0 $0 $15.10M $15.00M
Total Non-Current Liabilities $280K $0 $0 $0 $73K $143K $15.31M $15.00M
Total Liabilities $8.16M $9.66M $24.33M $27.81M $28.56M $29.67M $29.60M $33.60M
Total Debt (incl. Leases) $459K $143K $15.51M $15.53M $15.54M $15.56M $15.57M $15.30M
Common Stock $60K $60K $60K $60K $60K $60K $60K $60K
Retained Earnings -$496.6M -$492.9M -$487.4M -$484.0M -$477.5M -$469.8M -$460.0M -$450.1M
Accumulated Other Comp. Income -- -- -- $0 $815 -$11K $1.6K $37K
Total Stockholders' Equity $35.22M $37.89M $42.16M $44.25M $49.24M $55.29M $63.60M $71.00M
Total Equity $35.22M $37.89M $42.16M $44.25M $49.24M $55.29M $63.60M $71.00M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$33.85M -$55.85M -$37.54M -$62.02M -$57.78M -$37.55M -$60.83M -$38.89M -$22.34M -$18.70M
Depreciation & Amortization $252K $250K $263K $259K $264K $56K $96K $71K $38K $36K
Stock-Based Compensation $6.09M $7.97M $5.75M $8.29M $7.11M $7.08M $8.08M $4.14M $2.71M $2.76M
Change in Payables -$22K -$1.16M $1.20M -$886K $638K -$427K -$2.85M $2.05M $726K -$576K
Operating Cash Flow -$33.35M -$43.21M -$30.33M -$56.64M -$42.56M -$37.49M -$44.98M -$29.86M -$19.22M -$15.15M
Capital Expenditure -- -- $0 -$16K -$7.8K -- -$9.5K -$263K -$25K -$12K
Free Cash Flow -- -- -$30.33M -$56.65M -$42.56M -- -$44.99M -$30.12M -$19.25M -$15.16M
Purchases of Investments -$40.26M -$96.92M $0 -$92.94M $0 -$5.78M -- -- -- --
Investing Cash Flow $47.74M -$44.92M $30.00M -$29.95M -$7.8K $29.02M $18.48M -$23.34M -$10.20M -$225K
Common Stock Issued -- -- -- $0 $189.8M $40.72M $7.89M $81.84M $37.47M $12.65M
Financing Cash Flow $1.12M -$171K -$1.27M $1.22M $194.5M $41.90M $23.58M $80.53M $37.43M $12.74M
Net Change in Cash $15.51M -$88.30M -$1.60M -$85.37M $151.9M $33.43M -$2.93M $27.33M $8.01M -$2.63M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.76M -$5.45M -$3.45M -$6.46M -$7.69M -$9.77M -$9.93M -$15.81M
Depreciation & Amortization $155K $71K $67K $65K $64K $62K $61K $64K
Stock-Based Compensation $1.11M $1.64M -$988K $1.09M $2.58M $197K $2.22M $1.26M
Change in Payables $7.0K -$3.9K -$17K $145K -$1.02M $683K $166K -$6.5K
Operating Cash Flow -$4.12M -$4.59M -$5.11M -$5.30M -$7.02M -$8.56M -$12.47M -$12.04M
Purchases of Investments $0 $0 $0 $0 $0 -$24.55M -$15.71M -$21.56M
Investing Cash Flow $0 -$23K $0 $16.00M $25.00M -$554K $7.29M -$1.56M
Financing Cash Flow $9.7K -$15.30M $71K $0 $121K $0 $1.00M $7.8K
Net Change in Cash -$4.11M -$19.91M -$5.04M $10.70M $18.10M -$9.11M -$4.18M -$13.59M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -76.5% -78.7% -31.3% -41.1% -28.1% -63.1% -126.5% -44.9% -56.4% -86.4%
Return on Assets (ROA) -47.0% -53.4% -25.3% -34.2% -24.8% -45.1% -80.5% -40.9% -50.6% -74.2%
Current Ratio 2.58x 5.59x 6.64x 11.78x 19.77x 6.69x 5.82x 11.18x 13.11x 10.93x
Quick Ratio 2.52x 5.44x -- 11.35x 19.52x 6.27x 3.44x 5.59x 5.97x 10.83x
Debt to Equity 0.35x 0.22x 0.13x 0.11x 0.08x 0.20x 0.31x 0.19x 0.03x 0.06x
5Y Net Income / Share Growth -- -- -- -- -- -- -- -104.4% -- --
10Y Net Income / Share Growth -- -- -101.6% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -54.3% -60.8% -64.9% -76.5% -87.7% -91.6% -90.7% -78.7%
Return on Assets (ROA) -44.1% -48.5% -41.2% -47.0% -55.5% -59.6% -61.9% -53.4%
Current Ratio 5.45x 4.91x 2.72x 2.58x 2.72x 2.86x 6.49x 5.59x
Quick Ratio -- -- -- 2.52x 2.64x 2.77x 6.30x 5.44x
Debt to Equity 0.01x 0.00x 0.37x 0.35x 0.32x 0.28x 0.24x 0.22x
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -2505.3%
Source: SEC EDGAR CompanyFacts (CIK 0001341235) · from March 31, 2013 Data through September 30, 2026 · synced Nov 21, 2026, 05:00 UTC · Open in terminal